Keyphrases
Mali
100%
Fluorescent Microscopy
100%
Tuberculosis Patients
100%
Multidrug-resistant Tuberculosis (MDR-TB)
100%
Rifampicin Resistance
100%
Xpert
83%
Acid-fast Bacilli
50%
GeneXpert
50%
Sputum
50%
Drug Susceptibility Testing
33%
Microscopy
16%
Treatment Efficacy
16%
Patient's Will
16%
Sputum Samples
16%
Lost to Follow-up
16%
Resistance-based
16%
Screening Strategy
16%
Low Mortality
16%
Prospective Cohort Study
16%
Low Prevalence
16%
Health Centers
16%
Bamako
16%
Sputum Smear
16%
Tuberculosis Treatment
16%
Early Referral
16%
Acquired Drug Resistance
16%
Treatment Predictors
16%
World Health Organization Guidelines
16%
Screening Algorithm
16%
HIV Co-infection
16%
Smear Conversion
16%
Tuberculosis Coinfection
16%
Medicine and Dentistry
Fluorescence Microscopy
100%
Rifampicin
100%
Multidrug Resistant Tuberculosis
100%
Sputum
66%
Acid Fast Bacterium
50%
Prevalence
33%
Human Immunodeficiency Virus
33%
Tuberculosis Treatment
33%
Drug Sensitivity
33%
Prospective Study
16%
Mixed Infection
16%
Prospective Cohort Study
16%
Patient Referral
16%
Sputum Smear
16%
Drug Resistance
16%
Pharmacology, Toxicology and Pharmaceutical Science
Multi-Drug-Resistant Tuberculosis
100%
Rifampicin
100%
Acid Fast Bacterium
50%
HIV
33%
Prevalence
33%
Prospective Study
16%
Prospective Cohort Study
16%
Mixed Infection
16%
Drug Resistance
16%
Immunology and Microbiology
Multi-Drug-Resistant Tuberculosis
100%
Sputum
83%
Acid Fast Bacterium
50%
Prevalence
33%
Human Immunodeficiency Virus
33%
Drug Sensitivity
33%
Coinfection
16%
Drug Resistance
16%
Neuroscience
Rifampicin
100%
Multi-Drug-Resistant Tuberculosis
100%
Human Immunodeficiency Virus
33%
Drug Resistance
16%